Quiz
MO21 Nucleic acids as therapeutics
Este quiz tem tipos de pergunta que abrem no player de sempre.
Perguntas do quiz (8)
1Which of these biopharmaceuticals is not a nucleic acid?
- ADNA
- BRNA
- Cantisense oligonucleotides
- Dantibodies
2Gene [blank_start]replacement therapy[blank_end] is used to treat diseases caused by a mutation that stops a gene from producing a functioning product, a protein. The aim is to [blank_start]add DNA[blank_end] containing a functional version of the lost gene back into the cell. The new gene produces a [blank_start]functioning[blank_end] product at [blank_start]sufficient[blank_end] levels to replace the protein that was originally missing.
Gene [blank_start]inhibition therapy[blank_end] is suitable for the treatment of infectious diseases, cancer and inherited disease caused by [blank_start]inappropriate[blank_end] gene activity. The aim is to [blank_start]introduce[blank_end] a gene whose product [blank_start]inhibits[blank_end] the expression of another gene.
Gene [blank_start]cell killing therapy[blank_end] is suitable for diseases such as [blank_start]cancer[blank_end] that can be treated by destroying certain groups of cells. The aim is to insert DNA into a diseased cell that causes that cell to [blank_start]die[blank_end].- Areplacement therapy
- Binhibition therapy
- Ccell killing therapy
- Dadd DNA
- Efunctioning
- Fsufficient
- Ginappropriate
- Hintroduce
- Iinhibits
- Jcancer
- Kdie
3Order these basic steps of how gene therapy works.
[blank_start]2[blank_end]. The target cells become infected with the viral vector
[blank_start]1[blank_end]. A vector delivers the therapeutic gene into a patient’s target cell
[blank_start]4[blank_end]. Functional proteins are created from the therapeutic gene causing the cell to return to a normal state
[blank_start]3[blank_end]. The vector’s genetic material is inserted into the target cell- A2
- B1
- C3
- D4
- E1
- F2
- G3
- H4
- I4
- J1
- K2
- L3
- M3
- N1
- O2
- P4
4Which of these is not an ideal quality for a vector?
- AEasy and efficient to produce
- BTargets specific cell or tissue
- CProtects the DNA
- DImmunogenic
5There are two types of vectors: viral and non-viral.
Viral vectors are very [blank_start]efficient[blank_end] at transfecting cells. However, there are worries about disabled viruses regaining [blank_start]virility[blank_end], [blank_start]immune[blank_end] reactions, and/or viral therapy integrating into the genome causing [blank_start]disease (cancer)[blank_end].
Non-viral vectors mix DNA with a [blank_start]cationic[blank_end] carrier, either a [blank_start]liposome[blank_end] or a [blank_start]nanoparticle[blank_end], to form lipoplexes and nanoplexes respectively.- Aefficient
- Bvirility
- Cimmune
- Ddisease (cancer)
- Ecationic
- Fanionic
- Gliposome
- Hnanoparticle
6Viral vector advantages:
• [blank_start]High uptake[blank_end] into cells
• Can be [blank_start]modified[blank_end] to target specific cells
• They are modified so [blank_start]don’t replicate and kill[blank_end] the target cell
Viral vector disadvantages:
• Gene size is [blank_start]limited[blank_end]
• Patients [blank_start]immune response[blank_end] to the virus results in poor response
• Potential to [blank_start]integrate into genome[blank_end] causing disease (cancer)- AHigh uptake
- Bmodified
- Cdon’t replicate and kill
- Dlimited
- Eimmune response
- Fintegrate into genome
7Non-viral vector advantages:
• [blank_start]No immune[blank_end] response
• [blank_start]Easily[blank_end] formulated and assembles
• [blank_start]Cheaper[blank_end]
• Gene size [blank_start]not limited[blank_end]
• Cell/tissue targeting
Non-viral vector disadvantages:
• [blank_start]Low levels[blank_end] of gene expression (difficult to get into cell and make work)- ANo immune
- BEasily
- CCheaper
- Dnot limited
- ELow levels
8Which of these is not an obstacle to success for gene therapy?
- AInefficient gene delivery to target cells
- BInadequate gene expression
- CUnacceptable adverse effects
- DAvoiding the immune response
- EThe cost
- FPotential to cure pathologies
Informações
- Descrição
- PHCY211 (Molecules) Quiz sobre MO21 Nucleic acids as therapeutics, criado por Mer Scott em 14-04-2018.
- Autor
- Mer Scott
- Idioma
- English
- Visualizações
- 7
- Histórico
- Criado em 14 abr 2018 · atualizado em 14 abr 2018
- Etiquetas
- Avaliação
- Ainda sem avaliações Avalie este quiz